Related Experiment Video
Updated: Oct 4, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report
Yuki Meda1, Hideo Miyake1, Hidemasa Nagai1
1Department of Gastrointestinal Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.
Abstract:
A new classification of SMARCA4-deficient tumors was proposed recently for thoracic malignancies, and the tumors have some histopathological characteristics similar to those of carcinosarcoma. We encountered a case of SMARCA4-deficient rectal carcinoma with a sarcomatoid component. A 46-year-old man presented to our hospital with a prolapsing anal mass. Colonoscopy revealed an irregular, nodular, and elevated lesion in the rectum, and the biopsy revealed a moderately differentiated adenocarcinoma. Abdominoperineal resection of the rectum was performed. A macroscopic image of the resected specimen showed a complex tumor 3.5 cm × 3 cm in size with a papillary protrusion and an irregular ulcerative lesion. Histopathological examination revealed that the tumor was composed of moderately/poorly differentiated adenocarcinoma and atypical spindle cells. The adenocarcinoma component was positive for epithelial markers (AE1/AE3 and carcinoembryonic antigen) and showed deletion of SMARCA2 and SMARCA4, while the spindle cells expressed mesenchymal markers (α-smooth muscle actin and vimentin). The pathological diagnosis was poorly differentiated adenocarcinoma with a sarcomatoid component, pT3N2bM0, stage IIIc. Although our case had histological characteristics of carcinosarcoma, immunostaining revealed a deficiency of SMARCA4. This case presented a SMARCA4-deficient colorectal carcinoma with a sarcomatoid component, which was histopathologically similar to carcinosarcoma.
Insights
A rare case of SMARCA4-deficient rectal carcinoma with a sarcomatoid component, mimicking carcinosarcoma, was identified. This finding expands the understanding of SMARCA4-deficient tumors in colorectal cancer.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- A recent classification proposed SMARCA4-deficient tumors in thoracic malignancies, noting similarities to carcinosarcoma.
- SMARCA4-deficient tumors are increasingly recognized across various cancer types.
Observation:
- A 46-year-old male presented with a rectal mass.
- Initial biopsy showed moderately differentiated adenocarcinoma.
- Resected specimen revealed a complex tumor with adenocarcinoma and atypical spindle cells.
Findings:
- The tumor exhibited both adenocarcinoma and sarcomatoid components.
- Immunohistochemistry confirmed SMARCA4 deficiency in the adenocarcinoma cells.
- Spindle cells expressed mesenchymal markers, while adenocarcinoma cells expressed epithelial markers.
Implications:
- This case represents a SMARCA4-deficient colorectal carcinoma with a sarcomatoid component.
- The histological features resemble carcinosarcoma, highlighting diagnostic challenges.
- This finding contributes to the characterization of SMARCA4-deficient neoplasms in the colorectum.

